Literature DB >> 5471209

The use of propranolol in arrhythmias complicating acute myocardial infarction.

L Lemberg, A Castellanos, A G Arcebal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5471209     DOI： 10.1016/0002-8703(70)90195-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  8 in total

1.  Metoprolol--a new cardioselective beta-adrenoceptor blocking agent for treatment of tachyarrhythmias.

Authors:  H S Wasir; R K Mahapatra; M L Bhatia; S B Roy; R Sannerstedt
Journal:  Br Heart J       Date:  1977-08

2.  [Drug therapy of tachyarrhythmias (author's transl)].

Authors:  K Theisen
Journal:  Klin Wochenschr       Date:  1978-02-15

Review 3.  Beta-adrenoceptor blocking drugs and acute myocardial infarction.

Authors:  B N Singh
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

Review 4.  Digitalis and verapamil in atrial fibrillation and flutter. Is verapamil now the preferred agent?

Authors:  H O Klein; E Kaplinsky
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

Review 5.  Beta adrenoceptor antagonists after myocardial infarction--where are we now?

Authors:  D A Chamberlain
Journal:  Br Heart J       Date:  1983-02

Review 6.  Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.

Authors:  B N Singh; D E Jewitt
Journal:  Drugs       Date:  1974       Impact factor: 9.546

7.  Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease.

Authors:  H J Jürgensen; J Dalsgaard-Nielsen; E Kjøller; J Gormsen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 8.  The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.

Authors:  S Nattel; T Hadjis; M Talajic
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.